Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 685 to 692 of 692 entries
Sorted by: Best Match Show Resources per page
Infection Prevention and Control in Health Care, Part II: Management of Infections.

Infectious disease clinics of North America

Kaye KS, Dhar S.
PMID: 34752230
Infect Dis Clin North Am. 2021 Dec;35(4):xiii-xiv. doi: 10.1016/j.idc.2021.07.010.

No abstract available.

Cite
Kaye KS, Dhar S. Infection Prevention and Control in Health Care, Part II: Management of Infections. Infect Dis Clin North Am. 2021;35(4):xiii-xivdoi: 10.1016/j.idc.2021.07.010.
Kaye, K. S., & Dhar, S. (2021). Infection Prevention and Control in Health Care, Part II: Management of Infections. Infectious disease clinics of North America, 35(4), xiii-xiv. https://doi.org/10.1016/j.idc.2021.07.010
Kaye, Keith S, and Dhar, Sorabh. "Infection Prevention and Control in Health Care, Part II: Management of Infections." Infectious disease clinics of North America vol. 35,4 (2021): xiii-xiv. doi: https://doi.org/10.1016/j.idc.2021.07.010
Kaye KS, Dhar S. Infection Prevention and Control in Health Care, Part II: Management of Infections. Infect Dis Clin North Am. 2021 Dec;35(4):xiii-xiv. doi: 10.1016/j.idc.2021.07.010. PMID: 34752230; PMCID: PMC8553293.
Copy Download .nbib Format: NLM
Pain in nursing home residents with dementia and its association to quality of life.

Aging & mental health

Helvik AS, Bergh S, Šaltytė Benth J, Selbaek G, Husebo BS, Tevik K.
PMID: 34251936
Aging Ment Health. 2021 Jul 11;1-11. doi: 10.1080/13607863.2021.1947968. Epub 2021 Jul 11.

OBJECTIVES: We aimed to describe pain, use of analgesics and quality of life (QoL) in people with dementia admitted to a Norwegian nursing home (NH), and to explore if and how pain was associated with their QoL when adjusting...

Cite
Helvik AS, Bergh S, Šaltytė Benth J, et al. Pain in nursing home residents with dementia and its association to quality of life. Aging Ment Health. 2021;1-11doi: 10.1080/13607863.2021.1947968.
Helvik, A. S., Bergh, S., Šaltytė Benth, J., Selbaek, G., Husebo, B. S., & Tevik, K. (2021). Pain in nursing home residents with dementia and its association to quality of life. Aging & mental health, 1-11. https://doi.org/10.1080/13607863.2021.1947968
Helvik, Anne-Sofie, et al. "Pain in nursing home residents with dementia and its association to quality of life." Aging & mental health vol. (2021): 1-11. doi: https://doi.org/10.1080/13607863.2021.1947968
Helvik AS, Bergh S, Šaltytė Benth J, Selbaek G, Husebo BS, Tevik K. Pain in nursing home residents with dementia and its association to quality of life. Aging Ment Health. 2021 Jul 11;1-11. doi: 10.1080/13607863.2021.1947968. Epub 2021 Jul 11. PMID: 34251936.
Copy Download .nbib Format: NLM
Outcomes of preoperative real-time polymerase chain reaction testing for SARS CoV-2 in elective otolaryngology surgical patients during the pandemic: a prospective cohort study.

The British journal of surgery

Kavanagh FG, Brinkman D, James DL, O'Neill S, Murphy C, O'Riordan I, O'Flanagan G, Lang B, Keogh I, Lang E, Casserly P, Russell J, O'Brien D, Sheahan P.
PMID: 34426824
Br J Surg. 2021 Aug 24; doi: 10.1093/bjs/znab266. Epub 2021 Aug 24.

No abstract available.

Cite
Kavanagh FG, Brinkman D, James DL, et al. Outcomes of preoperative real-time polymerase chain reaction testing for SARS CoV-2 in elective otolaryngology surgical patients during the pandemic: a prospective cohort study. Br J Surg. 2021;doi: 10.1093/bjs/znab266.
Kavanagh, F. G., Brinkman, D., James, D. L., O'Neill, S., Murphy, C., O'Riordan, I., O'Flanagan, G., Lang, B., Keogh, I., Lang, E., Casserly, P., Russell, J., O'Brien, D., & Sheahan, P. (2021). Outcomes of preoperative real-time polymerase chain reaction testing for SARS CoV-2 in elective otolaryngology surgical patients during the pandemic: a prospective cohort study. The British journal of surgery, . https://doi.org/10.1093/bjs/znab266
Kavanagh, F G, et al. "Outcomes of preoperative real-time polymerase chain reaction testing for SARS CoV-2 in elective otolaryngology surgical patients during the pandemic: a prospective cohort study." The British journal of surgery vol. (2021). doi: https://doi.org/10.1093/bjs/znab266
Kavanagh FG, Brinkman D, James DL, O'Neill S, Murphy C, O'Riordan I, O'Flanagan G, Lang B, Keogh I, Lang E, Casserly P, Russell J, O'Brien D, Sheahan P. Outcomes of preoperative real-time polymerase chain reaction testing for SARS CoV-2 in elective otolaryngology surgical patients during the pandemic: a prospective cohort study. Br J Surg. 2021 Aug 24; doi: 10.1093/bjs/znab266. Epub 2021 Aug 24. PMID: 34426824; PMCID: PMC8499765.
Copy Download .nbib Format: NLM
Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial.

JAMA internal medicine

Ortigoza MB, Yoon H, Goldfeld KS, Troxel AB, Daily JP, Wu Y, Li Y, Wu D, Cobb GF, Baptiste G, O'Keeffe M, Corpuz MO, Ostrosky-Zeichner L, Amin A, Zacharioudakis IM, Jayaweera DT, Wu Y, Philley JV, Devine MS, Desruisseaux MS, Santin AD, Anjan S, Mathew R, Patel B, Nigo M, Upadhyay R, Kupferman T, Dentino AN, Nanchal R, Merlo CA, Hager DN, Chandran K, Lai JR, Rivera J, Bikash CR, Lasso G, Hilbert TP, Paroder M, Asencio AA, Liu M, Petkova E, Bragat A, Shaker R, McPherson DD, Sacco RL, Keller MJ, Grudzen CR, Hochman JS, Pirofski LA, Parameswaran L, Corcoran AT, Rohatgi A, Wronska MW, Wu X, Srinivasan R, Deng FM, Filardo TD, Pendse J, Blaser SB, Whyte O, Gallagher JM, Thomas OE, Ramos D, Sturm-Reganato CL, Fong CC, Daus IM, Payoen AG, Chiofolo JT, Friedman MT, Wu DW, Jacobson JL, Schneider JG, Sarwar UN, Wang HE, Huebinger RM, Dronavalli G, Bai Y, Grimes CZ, Eldin KW, Umana VE, Martin JG, Heath TR, Bello FO, Ransford DL, Laurent-Rolle M, Shenoi SV, Akide-Ndunge OB, Thapa B, Peterson JL, Knauf K, Patel SU, Cheney LL, Tormey CA, Hendrickson JE.
PMID: 34901997
JAMA Intern Med. 2021 Dec 13; doi: 10.1001/jamainternmed.2021.6850. Epub 2021 Dec 13.

IMPORTANCE: There is clinical equipoise for COVID-19 convalescent plasma (CCP) use in patients hospitalized with COVID-19.OBJECTIVE: To determine the safety and efficacy of CCP compared with placebo in hospitalized patients with COVID-19 receiving noninvasive supplemental oxygen.DESIGN, SETTING, AND PARTICIPANTS:...

Cite
Ortigoza MB, Yoon H, Goldfeld KS, et al. Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial. JAMA Intern Med. 2021;doi: 10.1001/jamainternmed.2021.6850.
Ortigoza, M. B., Yoon, H., Goldfeld, K. S., Troxel, A. B., Daily, J. P., Wu, Y., Li, Y., Wu, D., Cobb, G. F., Baptiste, G., O'Keeffe, M., Corpuz, M. O., Ostrosky-Zeichner, L., Amin, A., Zacharioudakis, I. M., Jayaweera, D. T., Wu, Y., Philley, J. V., Devine, M. S., Desruisseaux, M. S., Santin, A. D., Anjan, S., Mathew, R., Patel, B., Nigo, M., Upadhyay, R., Kupferman, T., Dentino, A. N., Nanchal, R., Merlo, C. A., Hager, D. N., Chandran, K., Lai, J. R., Rivera, J., Bikash, C. R., Lasso, G., Hilbert, T. P., Paroder, M., Asencio, A. A., Liu, M., Petkova, E., Bragat, A., Shaker, R., McPherson, D. D., Sacco, R. L., Keller, M. J., Grudzen, C. R., Hochman, J. S., Pirofski, L. A., Parameswaran, L., Corcoran, A. T., Rohatgi, A., Wronska, M. W., Wu, X., Srinivasan, R., Deng, F. M., Filardo, T. D., Pendse, J., Blaser, S. B., Whyte, O., Gallagher, J. M., Thomas, O. E., Ramos, D., Sturm-Reganato, C. L., Fong, C. C., Daus, I. M., Payoen, A. G., Chiofolo, J. T., Friedman, M. T., Wu, D. W., Jacobson, J. L., Schneider, J. G., Sarwar, U. N., Wang, H. E., Huebinger, R. M., Dronavalli, G., Bai, Y., Grimes, C. Z., Eldin, K. W., Umana, V. E., Martin, J. G., Heath, T. R., Bello, F. O., Ransford, D. L., Laurent-Rolle, M., Shenoi, S. V., Akide-Ndunge, O. B., Thapa, B., Peterson, J. L., Knauf, K., Patel, S. U., Cheney, L. L., Tormey, C. A., & Hendrickson, J. E. (2021). Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial. JAMA internal medicine, . https://doi.org/10.1001/jamainternmed.2021.6850
Ortigoza, Mila B, et al. "Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial." JAMA internal medicine vol. (2021). doi: https://doi.org/10.1001/jamainternmed.2021.6850
Ortigoza MB, Yoon H, Goldfeld KS, Troxel AB, Daily JP, Wu Y, Li Y, Wu D, Cobb GF, Baptiste G, O'Keeffe M, Corpuz MO, Ostrosky-Zeichner L, Amin A, Zacharioudakis IM, Jayaweera DT, Wu Y, Philley JV, Devine MS, Desruisseaux MS, Santin AD, Anjan S, Mathew R, Patel B, Nigo M, Upadhyay R, Kupferman T, Dentino AN, Nanchal R, Merlo CA, Hager DN, Chandran K, Lai JR, Rivera J, Bikash CR, Lasso G, Hilbert TP, Paroder M, Asencio AA, Liu M, Petkova E, Bragat A, Shaker R, McPherson DD, Sacco RL, Keller MJ, Grudzen CR, Hochman JS, Pirofski LA, Parameswaran L, Corcoran AT, Rohatgi A, Wronska MW, Wu X, Srinivasan R, Deng FM, Filardo TD, Pendse J, Blaser SB, Whyte O, Gallagher JM, Thomas OE, Ramos D, Sturm-Reganato CL, Fong CC, Daus IM, Payoen AG, Chiofolo JT, Friedman MT, Wu DW, Jacobson JL, Schneider JG, Sarwar UN, Wang HE, Huebinger RM, Dronavalli G, Bai Y, Grimes CZ, Eldin KW, Umana VE, Martin JG, Heath TR, Bello FO, Ransford DL, Laurent-Rolle M, Shenoi SV, Akide-Ndunge OB, Thapa B, Peterson JL, Knauf K, Patel SU, Cheney LL, Tormey CA, Hendrickson JE. Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial. JAMA Intern Med. 2021 Dec 13; doi: 10.1001/jamainternmed.2021.6850. Epub 2021 Dec 13. PMID: 34901997.
Copy Download .nbib Format: NLM
Strategies for Effective Infection Prevention Programs: Structures, Processes, and Funding.

Infectious disease clinics of North America

Dhar S, Sandhu AL, Valyko A, Kaye KS, Washer L.
PMID: 34362533
Infect Dis Clin North Am. 2021 Sep;35(3):531-551. doi: 10.1016/j.idc.2021.04.001.

Successful Infection Prevention Programs (IPPs) consist of a multidisciplinary team led by a hospital epidemiologist and managed by infection preventionists. Knowledge of the economics of health care-associated infections (HAIs) and the ability to make a business plan is now...

Cite
Dhar S, Sandhu AL, Valyko A, et al. Strategies for Effective Infection Prevention Programs: Structures, Processes, and Funding. Infect Dis Clin North Am. 2021;35(3):531-551doi: 10.1016/j.idc.2021.04.001.
Dhar, S., Sandhu, A. L., Valyko, A., Kaye, K. S., & Washer, L. (2021). Strategies for Effective Infection Prevention Programs: Structures, Processes, and Funding. Infectious disease clinics of North America, 35(3), 531-551. https://doi.org/10.1016/j.idc.2021.04.001
Dhar, Sorabh, et al. "Strategies for Effective Infection Prevention Programs: Structures, Processes, and Funding." Infectious disease clinics of North America vol. 35,3 (2021): 531-551. doi: https://doi.org/10.1016/j.idc.2021.04.001
Dhar S, Sandhu AL, Valyko A, Kaye KS, Washer L. Strategies for Effective Infection Prevention Programs: Structures, Processes, and Funding. Infect Dis Clin North Am. 2021 Sep;35(3):531-551. doi: 10.1016/j.idc.2021.04.001. PMID: 34362533.
Copy Download .nbib Format: NLM
Infection Prevention and Control in Health Care, Part 1: Facility Planning and Management.

Infectious disease clinics of North America

Kaye KS, Dhar S.
PMID: 34362547
Infect Dis Clin North Am. 2021 Sep;35(3):xiii-xiv. doi: 10.1016/j.idc.2021.04.002.

No abstract available.

Cite
Kaye KS, Dhar S. Infection Prevention and Control in Health Care, Part 1: Facility Planning and Management. Infect Dis Clin North Am. 2021;35(3):xiii-xivdoi: 10.1016/j.idc.2021.04.002.
Kaye, K. S., & Dhar, S. (2021). Infection Prevention and Control in Health Care, Part 1: Facility Planning and Management. Infectious disease clinics of North America, 35(3), xiii-xiv. https://doi.org/10.1016/j.idc.2021.04.002
Kaye, Keith S, and Dhar, Sorabh. "Infection Prevention and Control in Health Care, Part 1: Facility Planning and Management." Infectious disease clinics of North America vol. 35,3 (2021): xiii-xiv. doi: https://doi.org/10.1016/j.idc.2021.04.002
Kaye KS, Dhar S. Infection Prevention and Control in Health Care, Part 1: Facility Planning and Management. Infect Dis Clin North Am. 2021 Sep;35(3):xiii-xiv. doi: 10.1016/j.idc.2021.04.002. PMID: 34362547; PMCID: PMC8331240.
Copy Download .nbib Format: NLM
Heterometallic tetranuclear [Ln(III)2Co(III)2] complexes including suppression of quantum tunneling of magnetization in the [Dy(III)2Co(III)2] single molecule magnet.

Inorganic chemistry

Langley SK, Chilton NF, Ungur L, Moubaraki B, Chibotaru LF, Murray KS.
PMID: 23072350
Inorg Chem. 2012 Nov 05;51(21):11873-81. doi: 10.1021/ic301784m. Epub 2012 Oct 16.

Using a heterometallic approach the synthesis, structures, and magnetic properties are reported for the complexes [Ln(III)(2)Co(III)(2)(OMe)(2)(teaH)(2)(O(2)CPh)(4)(MeOH)(4)](NO(3))(2)·MeOH·H(2)O {Ln = Gd (1a), Tb (2a), and Dy (3a)} and [Ln(III)(2)Co(III)(2)(OMe)(2)(teaH)(2)(O(2)CPh)(4)(MeOH)(2)(NO(3))(2)]·MeOH·H(2)O {Ln = Gd (1b), Tb (2b), and Dy (3b)}. Both compounds for...

Cite
Langley SK, Chilton NF, Ungur L, et al. Heterometallic tetranuclear [Ln(III)2Co(III)2] complexes including suppression of quantum tunneling of magnetization in the [Dy(III)2Co(III)2] single molecule magnet. Inorg Chem. 2012;51(21):11873-81doi: 10.1021/ic301784m.
Langley, S. K., Chilton, N. F., Ungur, L., Moubaraki, B., Chibotaru, L. F., & Murray, K. S. (2012). Heterometallic tetranuclear [Ln(III)2Co(III)2] complexes including suppression of quantum tunneling of magnetization in the [Dy(III)2Co(III)2] single molecule magnet. Inorganic chemistry, 51(21), 11873-81. https://doi.org/10.1021/ic301784m
Langley, Stuart K, et al. "Heterometallic tetranuclear [Ln(III)2Co(III)2] complexes including suppression of quantum tunneling of magnetization in the [Dy(III)2Co(III)2] single molecule magnet." Inorganic chemistry vol. 51,21 (2012): 11873-81. doi: https://doi.org/10.1021/ic301784m
Langley SK, Chilton NF, Ungur L, Moubaraki B, Chibotaru LF, Murray KS. Heterometallic tetranuclear [Ln(III)2Co(III)2] complexes including suppression of quantum tunneling of magnetization in the [Dy(III)2Co(III)2] single molecule magnet. Inorg Chem. 2012 Nov 05;51(21):11873-81. doi: 10.1021/ic301784m. Epub 2012 Oct 16. PMID: 23072350.
Copy Download .nbib Format: NLM
Current State of Information Technologies for the Clinical Research Enterprise across Academic Medical Centers.

Weber GM, Murphy SN, Dubey A, Embi PJ, Harris PA, Richter BG, Turisco F, Tcheng JE, Keogh D.
UIID-AD: 1362
2012;5:281-284. doi: 10.1111/j.1752-8062.2011.00387.x.

Information technology (IT) to support clinical research has steadily grown over the past 10 years. Many new applications at the enterprise level are available to assist with the numerous tasks necessary in performing clinical research. However, it is not...

Cite
Weber GM, Murphy SN, Dubey A, et al. Current State of Information Technologies for the Clinical Research Enterprise across Academic Medical Centers. 2012;5:281-284doi: 10.1111/j.1752-8062.2011.00387.x.
Weber, G. M., Murphy, S. N., Dubey, A., Embi, P. J., Harris, P. A., Richter, B. G., Turisco, F., Tcheng, J. E., & Keogh, D. (2012). Current State of Information Technologies for the Clinical Research Enterprise across Academic Medical Centers. 5281-284. https://doi.org/10.1111/j.1752-8062.2011.00387.x
Weber, G M, et al. "Current State of Information Technologies for the Clinical Research Enterprise across Academic Medical Centers." vol. 5 (2012): 281-284. doi: https://doi.org/10.1111/j.1752-8062.2011.00387.x
Weber GM, Murphy SN, Dubey A, Embi PJ, Harris PA, Richter BG, Turisco F, Tcheng JE, Keogh D. Current State of Information Technologies for the Clinical Research Enterprise across Academic Medical Centers. 2012;5:281-284. doi: 10.1111/j.1752-8062.2011.00387.x. UIID-AD: 1362.
Copy Download .nbib Format: NLM
Showing 685 to 692 of 692 entries